| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 15.593 | 281 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 15.870 | 1.828 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 691 |
| Total Expenses - EUR | 15.828 | 35.700 | 3.552 | 5.940 | 11.794 | 195 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | 42 | -33.872 | -3.552 | -5.940 | -11.794 | -195 | 0 | 0 | 0 | 691 |
| Net Profit/Loss - EUR | 42 | -33.881 | -3.552 | -5.940 | -11.794 | -195 | 0 | 0 | 0 | 691 |
| Employees | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Farmatin Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 84.559 | 4.736 | 2.950 | 377 | 3.118 | 2.797 | 2.735 | 2.744 | 2.735 | 2.720 |
| Current Assets | 88.359 | 16.217 | 15.901 | 14.097 | 2.386 | 2.127 | 2.080 | 596 | 594 | 591 |
| Inventories | 41.760 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 45.869 | 16.106 | 15.833 | 13.875 | 2.168 | 2.127 | 2.080 | 596 | 594 | 591 |
| Cash | 730 | 112 | 68 | 222 | 218 | 0 | 0 | 0 | 0 | 0 |
| Shareholders Funds | 64.945 | -84.910 | -87.025 | -91.368 | -101.392 | -19.294 | -18.866 | -18.924 | -18.867 | -18.071 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 107.973 | 105.863 | 105.876 | 105.842 | 106.896 | 24.218 | 23.681 | 22.264 | 22.196 | 21.382 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Farmatin Srl